The partnership aims to introduce advanced cancer diagnostic and treatment technologies to Vietnam, expanding access to cutting-edge medical methods.
The signing ceremony took place in Hanoi on Friday, following a broader agreement reached in May between Vietnam's VNVC vaccine company, Tam Anh Hospital, and the Russian Direct Investment Fund (RDIF) during a visit by Vietnam's Party General Secretary To Lam to Russia.
RELATED NEWSRussia proposes medical tourism cooperation with Vietnam
The collaboration focuses on scientific research, technology transfer for vaccine and biopharmaceutical production, and the joint training of medical professionals in modern cancer care techniques.
Vietnam's Minister of Health Dao Hong Lan said the agreement symbolizes deepening medical cooperation between the two countries and will open pathways for high-quality healthcare services, scientific research, and the application of advanced technology.
This cooperation will foster practical programs in cancer treatment using advanced technology and in the production of vaccines and biological products, which are urgent needs not only for Vietnam and Russia but globally.Vietnamese Health Minister Dao Hong Lan
Russian Health Minister Mikhail Murashko said Russia's healthcare system is recognized by the World Health Organization as one of the best globally, highlighting its strengths in prevention, high-tech medicine, cancer treatment, and organ transplantation.
"This agreement is a significant step in realizing commitments made by the leadership of both countries toward improving healthcare for their people," Murashko said.
Ngo Chi Dung, chairman of Tam Anh Hospital and the Tam Anh Research Institute (TAMRI), said the partnership will bring Russia's pioneering cancer treatment innovations closer to Vietnamese patients and reduce the burden of cancer.
The cooperation involves comprehensive technology transfer, including vaccines, medicines, and diagnostic and treatment techniques, enabling Vietnam to produce its own advanced pharmaceuticals and reduce treatment costs while improving patient outcomes.
Tam Anh Hospital has prepared by investing in experienced medical staff, modern infrastructure, and international-standard laboratories, and has prior experience participating in global clinical cancer trials.
Following the signing, experts from both sides will conduct joint work sessions in Russia and Vietnam to accelerate the application of new medical advances.
The event also included a signing ceremony between Vietnam's VNVC vaccine and biological product company and Russia's Medsintez pharmaceutical company to collaborate on technology transfer, training, and production of next-generation vaccines and biopharmaceuticals.
Cancer remains a major public health challenge in Vietnam, with 180,400 new cases and 120,100 deaths annually, according to 2022 Globocan data.